MediWound Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for MediWound Ltd. (MDWD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-30.22-6.72-19.60-13.55-15.90-4.96-1.06
Depreciation & Amortization1.481.301.271.241.091.150.58
Stock Based Compensation3.141.941.951.671.320.000.00
Change in Working Capital1.272.42-7.240.160.454.14-1.01
Change in Accounts Receivable-1.145.66-7.580.931.390.000.00
Change in Inventory0.19-0.91-0.720.260.140.000.00
Change in Accounts Payable0.92-0.590.411.72-1.100.000.00
Change in Other Working Capital-0.01-1.820.65-2.75-0.490.000.00
Other Operating Activities-0.01-7.9211.741.560.812.92-11.49
Net Cash from Operating Activities-13.62-10.47-11.89-8.924.741.41-12.15
Investing Activities
Capital Expenditures-6.276.46-0.56-0.490.920.79-0.52
Purchases of Investments-4.38-29.800.004.0018.030.000.00
Sales/Maturities of Investments0.000.000.070.040.270.18-16.61
Other Investing Activities2.25-27.860.070.040.270.180.00
Net Cash from Investing Activities-8.40-34.32-0.483.55-0.65-1.85-17.04
Financing Activities
Debt Repayment-0.93-0.78-0.70-0.69-0.51-0.630.00
Common Stock Issued22.1724.9138.390.000.000.000.00
Other Financing Activities-3.98-1.21-1.93-0.36-0.42-0.810.05
Net Cash from Financing Activities19.3922.9235.76-1.05-0.93-1.440.05
Summary
Effect of Forex Changes on Cash-0.08-0.16-0.550.090.270.14-0.21
Net Change in Cash-2.63-21.8722.85-6.333.43-1.74-29.15
Cash at Beginning of Period11.8733.9011.0517.387.246.7236.07
Cash at End of Period9.1611.8722.729.3510.684.986.72
Free Cash Flow-19.90-16.93-12.44-9.413.810.62-12.69